Philippe Herman

2.0k total citations
54 papers, 1.4k citations indexed

About

Philippe Herman is a scholar working on Molecular Biology, Plant Science and Infectious Diseases. According to data from OpenAlex, Philippe Herman has authored 54 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 14 papers in Plant Science and 13 papers in Infectious Diseases. Recurrent topics in Philippe Herman's work include CRISPR and Genetic Engineering (18 papers), Genetically Modified Organisms Research (14 papers) and Animal Genetics and Reproduction (8 papers). Philippe Herman is often cited by papers focused on CRISPR and Genetic Engineering (18 papers), Genetically Modified Organisms Research (14 papers) and Animal Genetics and Reproduction (8 papers). Philippe Herman collaborates with scholars based in Belgium, France and United States. Philippe Herman's co-authors include Yves F. Dufrêne, Audrey Beaussart, Sofiane El‐Kirat‐Chatel, Nancy H. C. Roosens, Marie‐Alice Fraiture, Marc De Loose, Katia Pauwels, Dieter Deforce, David Alsteens and Isabel Taverniers and has published in prestigious journals such as Langmuir, Food Chemistry and Nature Protocols.

In The Last Decade

Philippe Herman

50 papers receiving 1.4k citations

Peers

Countries citing papers authored by Philippe Herman

Since Specialization

Citations

This map shows the geographic impact of Philippe Herman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Herman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Herman more than expected).

Fields of papers citing papers by Philippe Herman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Herman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Herman. The network helps show where Philippe Herman may publish in the future.

Co-authorship network of co-authors of Philippe Herman

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Herman. A scholar is included among the top collaborators of Philippe Herman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Herman. Philippe Herman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of a Droplet Digital PCR to Monitor SARS-CoV-2 Omicron Variant BA.2 in Wastewater Samples 2023 ·Microorganisms ·(unknown), (unknown), (unknown), Bavo Verhaegen, (unknown), Philippe Herman, Koenraad Van Hoorde, Nancy H. C. Roosens	5
2	Deepening of In Silico Evaluation of SARS-CoV-2 Detection RT-qPCR Assays in the Context of New Variants 2021 ·Genes ·(unknown), Kevin Vanneste, Isabelle Thomas, Steven Van Gucht, (unknown), Philippe Herman, Nancy H. C. Roosens, Sigrid C. J. De Keersmaecker	22
3	Strategy to Develop and Evaluate a Multiplex RT-ddPCR in Response to SARS-CoV-2 Genomic Evolution 2021 ·Current Issues in Molecular Biology ·(unknown), (unknown), Marie‐Alice Fraiture, Sigrid C. J. De Keersmaecker, Bavo Verhaegen, Koenraad Van Hoorde, Ann Brigitte Cay, Nadège Balmelle, Philippe Herman, Nancy H. C. Roosens	10
4	Use of Whole Genome Sequencing Data for a First in Silico Specificity Evaluation of the RT-qPCR Assays Used for SARS-CoV-2 Detection 2020 ·International Journal of Molecular Sciences ·(unknown), Kevin Vanneste, Isabelle Thomas, Steven Van Gucht, (unknown), Philippe Herman, Nancy H. C. Roosens, Sigrid C. J. De Keersmaecker	19
5	EAONO position statement on Vestibular Schwannoma: Imaging Assessment Question: How should growth of Vestibular Schwannoma be defined? 2018 ·The Journal of International Advanced Otology ·R. Kania, Benjamin Vérillaud, (unknown), Charlotte Hautefort, Thomas Somers, (unknown), Sébastien Froelich, Philippe Herman	11
6	Development and validation of an integrated DNA walking strategy to detect GMO expressing cry genes 2018 ·BMC Biotechnology ·Marie‐Alice Fraiture, (unknown), Philippe Herman, Nancy H. C. Roosens	8
7	An integrated strategy combining DNA walking and NGS to detect GMOs 2017 ·Food Chemistry ·Marie‐Alice Fraiture, Philippe Herman, Nina Papazova, Marc De Loose, Dieter Deforce, Tom Ruttink, Nancy H. C. Roosens	29
8	Biotech rice: Current developments and future detection challenges in food and feed chain 2016 ·Trends in Food Science & Technology ·Marie‐Alice Fraiture, Nancy H. C. Roosens, Isabel Taverniers, Marc De Loose, Dieter Deforce, Philippe Herman	32
9	Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination 2015 ·Human Vaccines & Immunotherapeutics ·Aline Baldo, Evanthia Galanis, Frédéric Tangy, Philippe Herman	35
10	Single-cell force spectroscopy of the medically important Staphylococcus epidermidis–Candida albicans interaction 2013 ·Nanoscale ·Audrey Beaussart, Philippe Herman, Sofiane El‐Kirat‐Chatel, Peter N. Lipke, Soňa Kucharíková, Patrick Van Dijck, Yves F. Dufrêne	73
11	Biosafety Risk Assessment and Management of Laboratory-Derived Influenza A (H5N1) Viruses Transmissible in Ferrets 2013 ·Applied Biosafety ·Aline Baldo, (unknown), (unknown), Didier Breyer, Katia Pauwels, Sarah Welby, (unknown), Philippe Herman	2
12	Engineering nucleases for gene targeting: safety and regulatory considerations 2013 ·New Biotechnology ·Katia Pauwels, Nancy Podevin, Didier Breyer, Dana Carroll, Philippe Herman	64
13	Chlamydia Psittaci , Causative Agent of Avian Chlamydiosis and Human Psittacosis: Risk Assessment and Biosafety Recommendations for Laboratory use 2012 ·Applied Biosafety ·(unknown), (unknown), (unknown), Philippe Herman, Lutgart Braeckman, Daisy Vanrompay	4
14	Contained use of Bacteriophages: Risk Assessment and Biosafety Recommendations 2010 ·Applied Biosafety ·Céline Verheust, Katia Pauwels, Jacques Mahillon, Donald R. Helinski, Philippe Herman	39
15	Contributions from scientific research to the risk assessment of GMOs. Lessons learned from a symposium held in Brussels, Belgium, 21–22 October 2010 2010 ·PubMed ·Katia Pauwels, Didier Breyer, Adinda de Schrijver, Martine Goossens, Philippe Herman	2
16	Biosafety considerations associated with molecular farming in genetically modified plants. 2009 ·Journal of Medicinal Plants Research ·Didier Breyer, Martine Goossens, Philippe Herman, Myriam Sneyers	18
17	Cervical necrotizing fasciitis: 8-years’ experience of microbiology 2008 ·European Journal of Clinical Microbiology & Infectious Diseases ·Vincent Fihman, Laurent Raskine, Franck Petitpas, Joaquim Matéo, R. Kania, (unknown), Matthieu Resche‐Rigon, (unknown), Béatrice Berçot, Didier Payen, M.-J. Sanson-Le Pors, Philippe Herman, Alexandre Mebazaa	26
18	Animal Cell Cultures: Risk Assessment and Biosafety Recommendations 2007 ·Applied Biosafety ·Katia Pauwels, Philippe Herman, (unknown), (unknown), (unknown), (unknown), Dirk Van Bockstaele, Karoline Dorsch‐Häsler, Myriam Sneyers	9
19	Biosafety Risk Assessment of the Severe Acute Respiratory Syndrome (SARS) Coronavirus and Containment Measures for the Diagnostic and Research Laboratories 2004 ·Applied Biosafety ·Philippe Herman, (unknown), Didier Breyer, (unknown), B. Brochier, Myriam Sneyers, R Snacken, P. Hermans, Pierre Kerkhofs, Corinne Liesnard, B. Rombaut, Marc Van Ranst, Guido van der Groen, Patrick Goubau, William Moens	6
20	Ion transports in the middle ear epithelium. 1998 ·PubMed ·Philippe Herman, Ching‐Ting Tan, François Portier, Carlo Alfredo Clerici, Brigitte Escoubet, Gérard Friedlander, (unknown)	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact